Sveriges mest populära poddar
PharmaSource Podcast
VetenskapLife Science

Recipharm’s CDMO Evolution: Technology Investment Powering Global Growth

24 min•19 mars 2025

“Every minute, over 1000 patients are using a product manufactured in one of our sites,” reveals Kerstin Vieluf, Head of Sales at Recipharm.

Headquartered in Stockholm, Sweden, Recipharm has over 5,900 employees across 17 sites in Europe, US, India, and Israel and serves more than 400 customers globally.

In this exclusive interview ahead of CDMO Live, the leadership team outlines how Recipharm is evolving its capabilities, with significant investments in digital prediction tools, expanded development services, and sustainability initiatives. Dr. Vincenza Pironti, (Head of Business Development), Dr. Uwe Hanenberg (Head of Product Development), and Dr. Kerstin Vieluf, (Head of Sales) reveal how technology investment is driving growth.

Read the full article

Fler avsnitt av PharmaSource Podcast

Visa alla avsnitt av PharmaSource Podcast
How the BMC Achieves Clinical-to-Commercial Quality Continuity Across Its Biologics CDMO Platform
•23 min
Digital Twins in Claude: How BioPharma Can Build Forecast and Supply Models
•30 min
Hybrid Synthesis is Redefining Peptide Manufacturing
•29 min
The Case for Strategic CDMO Partnerships Over Multi-Sourcing
•32 min
CDMO Consolidation “Inevitable” Without Business Model Shift, Warns Cell Therapy CEO
•47 min
Trump's Most-Favored-Nation Policy Is Forcing Europe's Pharma Industry to Reconsider Its Pricing Strategy
•27 min
How Europe’s Critical Medicines Act Could Reshape Generic Drug Supply Chains
•22 min
Reshoring America’s Critical Medicines: How the API Innovation Center Turns Idle Capacity Into a Drug Security Strategy
•36 min
How Radiopharmaceutical Supply Chains Win the Race Against Radioactive Decay: Insights from Daniel Rossetto, ARTBIO
•31 min
U.S. Vaccine Policy Shifts are Create a “Chilling” Effect on Global Manufacturing and Innovation
•35 min

PharmaSource Podcast med Life Science Networks finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.